AP
PGEN icon

Arlington Partners’s Precigen PGEN Stock Holding History

Arlington Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$3K – 432
2022
Q2 		$3K Hold
2,000
– – ﹤0.01% 448
2022
Q1 		$4K Hold
2,000
– – ﹤0.01% 432
2021
Q4 		$7K Buy
+2,000
New +$8.61K ﹤0.01% 535
2018
Q4 		– Sell
-1,000
Closed -$17K – 248
2018
Q3 		$17K Buy
+1,000
New +$14.9K 0.01% 180

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arlington Partners's PGEN Position: Q3 2022 in Review

Arlington Partners sold out of Precigen (PGEN) in Q3 2022, closing a stake of 2,000 shares — an estimated $3K sold.

Arlington Partners first reported a position in PGEN in Q3 2018 and held it in 4 quarters. The position peaked at $17K in Q3 2018. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

  • Arlington Partners reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
  • Arlington Partners sold 2,000 Precigen shares in Q3 2022, an estimated $3K.
  • Arlington Partners first reported a position in Precigen in Q3 2018 and held it in 4 quarters.
  • Arlington Partners's Precigen position peaked at $17K in Q3 2018.
  • 165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on Arlington Partners's 13F filing for Q3 2022, filed 28 Oct 2022.